JP2024129139A5 - - Google Patents

Download PDF

Info

Publication number
JP2024129139A5
JP2024129139A5 JP2024108991A JP2024108991A JP2024129139A5 JP 2024129139 A5 JP2024129139 A5 JP 2024129139A5 JP 2024108991 A JP2024108991 A JP 2024108991A JP 2024108991 A JP2024108991 A JP 2024108991A JP 2024129139 A5 JP2024129139 A5 JP 2024129139A5
Authority
JP
Japan
Prior art keywords
drawings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024108991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024129139A (ja
Filing date
Publication date
Priority claimed from JP2020067797A external-priority patent/JP2020128375A/ja
Application filed filed Critical
Publication of JP2024129139A publication Critical patent/JP2024129139A/ja
Publication of JP2024129139A5 publication Critical patent/JP2024129139A5/ja
Pending legal-status Critical Current

Links

JP2024108991A 2013-08-12 2024-07-05 ベンラリツマブを使用して喘息の増悪率を低減する方法 Pending JP2024129139A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361864944P 2013-08-12 2013-08-12
US61/864,944 2013-08-12
JP2020067797A JP2020128375A (ja) 2013-08-12 2020-04-03 ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2022092216A JP2022120009A (ja) 2013-08-12 2022-06-07 ベンラリツマブを使用して喘息の増悪率を低減する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022092216A Division JP2022120009A (ja) 2013-08-12 2022-06-07 ベンラリツマブを使用して喘息の増悪率を低減する方法

Publications (2)

Publication Number Publication Date
JP2024129139A JP2024129139A (ja) 2024-09-26
JP2024129139A5 true JP2024129139A5 (https=) 2025-05-26

Family

ID=52448837

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016534614A Active JP6746495B2 (ja) 2013-08-12 2014-08-07 ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2020067797A Withdrawn JP2020128375A (ja) 2013-08-12 2020-04-03 ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2022092216A Pending JP2022120009A (ja) 2013-08-12 2022-06-07 ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2024108991A Pending JP2024129139A (ja) 2013-08-12 2024-07-05 ベンラリツマブを使用して喘息の増悪率を低減する方法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2016534614A Active JP6746495B2 (ja) 2013-08-12 2014-08-07 ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2020067797A Withdrawn JP2020128375A (ja) 2013-08-12 2020-04-03 ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2022092216A Pending JP2022120009A (ja) 2013-08-12 2022-06-07 ベンラリツマブを使用して喘息の増悪率を低減する方法

Country Status (26)

Country Link
US (2) US9441037B2 (https=)
EP (1) EP3033101B1 (https=)
JP (4) JP6746495B2 (https=)
KR (2) KR20220057637A (https=)
CN (2) CN105451760A (https=)
AU (2) AU2014306956B2 (https=)
BR (1) BR112016002401A8 (https=)
CA (1) CA2918105C (https=)
CY (1) CY1122132T1 (https=)
DK (1) DK3033101T3 (https=)
ES (1) ES2716906T3 (https=)
HK (2) HK1225302B (https=)
HR (1) HRP20190405T1 (https=)
HU (1) HUE042607T2 (https=)
LT (1) LT3033101T (https=)
ME (1) ME03348B (https=)
MX (1) MX368508B (https=)
PL (1) PL3033101T3 (https=)
PT (1) PT3033101T (https=)
RS (1) RS58404B1 (https=)
RU (1) RU2676333C2 (https=)
SG (2) SG10202005560UA (https=)
SI (1) SI3033101T1 (https=)
SM (1) SMT201900163T1 (https=)
TR (1) TR201903312T4 (https=)
WO (1) WO2015023504A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111617244A (zh) * 2013-08-12 2020-09-04 阿斯特拉捷利康股份公司 使用贝那利珠单抗改善哮喘症状的方法
US9441046B2 (en) * 2013-08-12 2016-09-13 Astrazeneca Ab Methods for increasing forced expiratory volume in asthmatics using benralizumab
KR20160061352A (ko) * 2013-10-15 2016-05-31 메디뮨 엘엘씨 벤랄리주맙을 사용하여 만성 폐쇄성 폐 질환을 치료하는 방법
SI3060229T1 (sl) 2013-10-24 2021-11-30 Astrazeneca Ab Stabilne vodne formulacije protiteles
SG11201605580RA (en) 2014-01-10 2016-10-28 Anaptysbio Inc Antibodies directed against interleukin-33 (il-33)
US10699274B2 (en) 2015-08-24 2020-06-30 Samsung Electronics Co., Ltd. Apparatus and method for secure electronic payment
US10846696B2 (en) 2015-08-24 2020-11-24 Samsung Electronics Co., Ltd. Apparatus and method for trusted execution environment based secure payment transactions
JP2018538249A (ja) 2015-11-04 2018-12-27 アストラゼネカ アクチボラグ 好酸球性疾患における好酸球標的化治療薬に対する臨床応答の予測変数としてのジペプチジルペプチダーゼ−4およびペリオスチン
WO2018127830A1 (en) * 2017-01-04 2018-07-12 Apitope International Nv S-arrestin peptides and therapeutic uses thereof
RU2698048C2 (ru) * 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
TW202021983A (zh) * 2018-09-21 2020-06-16 美商安納普提斯生物公司 用於嗜伊紅性氣喘之抗il-33療法
TW202214692A (zh) * 2020-06-05 2022-04-16 瑞典商阿斯特捷利康公司 治療患有鼻瘜肉的患者的重度氣喘之方法
WO2025264860A2 (en) 2024-06-18 2025-12-26 Yale University Methods of treating post-covid airway disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1241944C (zh) 1995-09-11 2006-02-15 协和发酵工业株式会社 抗人白介素-5受体α链的抗体
US6746839B1 (en) * 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
EP1176195B1 (en) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
US7404953B2 (en) 2000-02-15 2008-07-29 Kyowa Hakko Kogyo Co., Ltd. Methods using eosinophil-specific apoptosis inducer
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US7662925B2 (en) 2002-03-01 2010-02-16 Xencor, Inc. Optimized Fc variants and methods for their generation
AU2004279740A1 (en) 2003-10-08 2005-04-21 Kyowa Hakko Kirin Co., Ltd. Antibody composition specifically binding to IL-5 receptor
US20060014680A1 (en) 2004-07-13 2006-01-19 Caiding Xu Peptides and compounds that bind to the IL-5 receptor
WO2007041635A2 (en) 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
HUE036885T2 (hu) 2007-05-14 2018-08-28 Astrazeneca Ab Eljárás a bazofil-szint csökkentésére
RU2383345C1 (ru) * 2008-08-07 2010-03-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") Способ лечения больных бронхиальной астмой
US20110117213A1 (en) * 2009-11-18 2011-05-19 Medicinova, Inc. Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
TWI732259B (zh) * 2010-12-16 2021-07-01 美商建南德克公司 關於th2抑制作用之診斷及治療
EP2710370A4 (en) * 2011-05-18 2015-01-07 Medimmune Llc METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS
HK1201440A1 (en) 2011-11-01 2015-09-04 Medimmune, Llc Methods for reducing the frequency and severity of acute exacerbations of asthma
US9441046B2 (en) 2013-08-12 2016-09-13 Astrazeneca Ab Methods for increasing forced expiratory volume in asthmatics using benralizumab
CN111617244A (zh) * 2013-08-12 2020-09-04 阿斯特拉捷利康股份公司 使用贝那利珠单抗改善哮喘症状的方法

Similar Documents

Publication Publication Date Title
JP2025138632A5 (https=)
JP2024116190A5 (https=)
JP2024129139A5 (https=)
JP2025138641A5 (https=)
JP2022191211A5 (https=)
JP2023171775A5 (https=)
JP2023103258A5 (https=)
JP2022184985A5 (https=)
JP2025176106A5 (https=)
JP2024161376A5 (https=)
JP2024114921A5 (https=)
JP2025118629A5 (https=)
JP2023145572A5 (https=)
JP2026004279A5 (https=)
JP2023181322A5 (https=)
JP2025098156A5 (https=)
JP2024045126A5 (https=)
JP2025090801A5 (https=)
JP2025094038A5 (https=)
JP2024149687A5 (https=)
JPWO2019148052A5 (https=)
JP2024099716A5 (https=)
JP2025081323A5 (https=)
JP2023093656A5 (https=)
JP2024099585A5 (https=)